Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Efficacy of Campath in Nonmyeloablative Transplantation

Trial Profile

Safety and Efficacy of Campath in Nonmyeloablative Transplantation

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs Alemtuzumab (Primary) ; Cyclophosphamide; Fludarabine; Rituximab
  • Indications Leukaemia; Lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top